Ackman: Allergan Not Being Raided in Valeant Deal

April 23 (Bloomberg) -- Bill Ackman, CEO at Pershing Square Capital and Michael Pearson, Chairman/CEO at Valeant Pharmaceuticals, discuss their joint bid for Allergan and explain how and why they partnered for the deal on Bloomberg Television’s “Market Makers.” (Source: Bloomberg)

Are ETFs Weapons of Mass Destruction?
46:43 - Bloomberg Intelligence's Eric Balchunas and Bloomberg's Abigail Doolittle look at criticisms of the ETF market and if they are valid. They speak on "Bloomberg Markets." (Source: Bloomberg)
  • Greenspan Says Trump's Budget 'Arithmetic' Is Wrong
  • What Is Shaping the Global Oil Market?
  • Rep. Crowley Says Trump’s First 100 Days Was Disastrous